Information: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Information:
Fel:
ID
9960
Beskrivning
Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
Nyckelord
Versioner (5)
- 2015-03-05 2015-03-05 -
- 2015-03-09 2015-03-09 -
- 2015-04-23 2015-04-23 -
- 2015-12-15 2015-12-15 -
- 2021-09-17 2021-09-17 -
Uppladdad den
9 mars 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0 Legacy
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Adverse Event AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Adverse Event AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Similar models
Adverse Event AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
CL Item
Diagnostic (0)
CL Item
Induction I (1)
CL Item
Induction II (optional) (2)
CL Item
Consolid. I (3)
CL Item
Consolid. II (4)
CL Item
Consolid. III (5)
CL Item
Consolid. IV (6)
CL Item
Maintenance (7)
CL Item
after 1 Month (1)
CL Item
after 2 Months (2)
CL Item
after 3 Months (3)
CL Item
after 4 Months (4)
CL Item
after 5 Months (5)
CL Item
after 6 Months (6)
CL Item
after 7 Months (7)
CL Item
after 8 Months (8)
CL Item
after 9Months (9)
CL Item
after 10 Months (10)
CL Item
after 11 Months (11)
CL Item
after 12 Months (12)
Desciption of Adverse Event
Item
Desciption of Adverse Event
text
C0877248 (UMLS CUI-1)
Adverse Event Term
Item
Adverse Event Term
text
C2826934 (UMLS CUI-1)
Serious Adverse Event
Item
Serious Adverse Event
boolean
C1519255 (UMLS CUI-1)
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
CL Item
Life-Threatening (4)
CL Item
Death related to AE (5)
CL Item
recovered (1)
CL Item
not yet recovered (2)
CL Item
recovered with sequelae (3)
CL Item
Death (4)
CL Item
unknown (5)
Treatment/Action taken
Item
Treatment/Action taken
text
C0087111 (UMLS CUI-1)
C0877248 (UMLS CUI-2)
C0877248 (UMLS CUI-2)
Adverse Event Start Date
Item
Adverse Event Start Date
date
C2697888 (UMLS CUI-1)
Adverse Event End Date
Item
Adverse Event End Date
date
C2697886 (UMLS CUI-1)
CL Item
definitely (1)
CL Item
probably (2)
CL Item
possible (3)
CL Item
unlikely (4)
CL Item
not related (5)
CL Item
Medication not administered (6)
CL Item
definitely (1)
CL Item
probably (2)
CL Item
possible (3)
CL Item
unlikely (4)
CL Item
not related (5)
CL Item
Medication not administered (6)
CL Item
definitely (1)
CL Item
probably (2)
CL Item
possible (3)
CL Item
unlikely (4)
CL Item
not related (5)
CL Item
Medication not administered (6)
CL Item
definitely (1)
CL Item
probably (2)
CL Item
possible (3)
CL Item
unlikely (4)
CL Item
not related (5)
CL Item
Medication not administered (6)
CL Item
definitely (1)
CL Item
probably (2)
CL Item
possible (3)
CL Item
unlikely (4)
CL Item
not related (5)
CL Item
Medication not administered (6)
CL Item
definitely (1)
CL Item
probably (2)
CL Item
possible (3)
CL Item
unlikely (4)
CL Item
not related (5)
CL Item
Medication not administered (6)
Date
Item
Date
date
C2346576 (UMLS CUI-1)
C0011008 (UMLS CUI-2)
C0011008 (UMLS CUI-2)
Name of Investigator
Item
Name of Investigator
text
C0008961 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)